Clinical TrialsLong-Acting Antibodies Delay HIV Rebound After ART Interruption, RIO Trial ... Long-Acting Antibodies Delay HIV Rebound After ART Interruption, RIO Trial ... Read Post »
Clinical TrialsCSL Seqirus aQIVc Shows Stronger Immune Response in Phase 3 CSL Seqirus aQIVc Shows Stronger Immune Response in Phase 3 Read Post »
Clinical TrialsSanofi’s SAR443820 Fails Phase 2 HIMALAYA Trial in ALS, Ending RIPK1 Prog... Sanofi’s SAR443820 Fails Phase 2 HIMALAYA Trial in ALS, Ending RIPK1 Prog... Read Post »
New Drug ApprovalSogroya Gets Positive EU Opinion for Idiopathic Short Stature Sogroya Gets Positive EU Opinion for Idiopathic Short Stature Read Post »
Clinical TrialsBiogen Reports Positive Adolescent Data for Empaveli in C3G and IC-MPGN Biogen Reports Positive Adolescent Data for Empaveli in C3G and IC-MPGN Read Post »
New Drug ApprovalFDA Approves FAYUVI for Sanfilippo Syndrome Type A FDA Approves FAYUVI for Sanfilippo Syndrome Type A Read Post »
Clinical TrialsSotyktu Shows Durable Efficacy in Psoriatic Arthritis at 2 Years Sotyktu Shows Durable Efficacy in Psoriatic Arthritis at 2 Years Read Post »
Clinical TrialsRoche’s Lunsumio Combination Improves Progression-Free Survival in Phase ... Roche’s Lunsumio Combination Improves Progression-Free Survival in Phase ... Read Post »
New Drug ApprovalFDA Approves Kerendia for Type 1 Diabetes-Associated CKD FDA Approves Kerendia for Type 1 Diabetes-Associated CKD Read Post »
Clinical TrialsNovo’s Denecimig Shows Tolerability After Direct Switch from Emicizumab i... Novo’s Denecimig Shows Tolerability After Direct Switch from Emicizumab i... Read Post »
Clinical TrialsNovartis Discontinues Lifonebart Development in ALS After ASTRALS Phase 2 F... Novartis Discontinues Lifonebart Development in ALS After ASTRALS Phase 2 F... Read Post »
Clinical TrialsLongeveron Laromestrocel Misses ELPIS II HLHS Endpoint Longeveron Laromestrocel Misses ELPIS II HLHS Endpoint Read Post »
Clinical TrialsRozanolixizumab Shows Limited Benefit in Severe Fibromyalgia Phase 2A Trial Rozanolixizumab Shows Limited Benefit in Severe Fibromyalgia Phase 2A Trial Read Post »
Clinical TrialsBoehringer Ingelheim Stops EASi-KIDNEY Trial of Vicadrostat in Chronic Kidn... Boehringer Ingelheim Stops EASi-KIDNEY Trial of Vicadrostat in Chronic Kidn... Read Post »
Clinical TrialsCan a Decades-Old Heart Drug Break Up Cancer Cell Clusters? Can a Decades-Old Heart Drug Break Up Cancer Cell Clusters? Read Post »
Clinical TrialsSKY-0515 Shows 1.59-Point cUHDRS Benefit in Huntington’s Disease SKY-0515 Shows 1.59-Point cUHDRS Benefit in Huntington’s Disease Read Post »
Clinical TrialsSYNT-101 Shows Placebo-Adjusted Weight Loss in 28-Day Phase 1 Obesity Study SYNT-101 Shows Placebo-Adjusted Weight Loss in 28-Day Phase 1 Obesity Study Read Post »
Clinical TrialsLilly Advances Obesity and Diabetes Pipeline With New EASD 2026 Data Lilly Advances Obesity and Diabetes Pipeline With New EASD 2026 Data Read Post »
Clinical TrialsNX210c Phase 2 ALS Trial Shows Reduced Functional Decline NX210c Phase 2 ALS Trial Shows Reduced Functional Decline Read Post »
Clinical TrialsRademikibart Improves Lung Function at Day 7 in Phase 2 Asthma Trial; Treat... Rademikibart Improves Lung Function at Day 7 in Phase 2 Asthma Trial; Treat... Read Post »
Clinical TrialsXKH004 Delivers Phase 3 Efficacy in Ankylosing Spondylitis With 45.4% ASAS4... XKH004 Delivers Phase 3 Efficacy in Ankylosing Spondylitis With 45.4% ASAS4... Read Post »
Clinical TrialsIvonescimab Shows Sustained Overall Survival Benefit in EGFR-Mutated NSCLC ... Ivonescimab Shows Sustained Overall Survival Benefit in EGFR-Mutated NSCLC ... Read Post »
Clinical TrialsTRUTAKNA Stabilized Kidney Function and Reduced Risk of Kidney Disease Prog... TRUTAKNA Stabilized Kidney Function and Reduced Risk of Kidney Disease Prog... Read Post »
New Drug ApprovalFDA Approves Curium’s BEXLUTRY as First Radioligand Equivalent to LUTATHE... FDA Approves Curium’s BEXLUTRY as First Radioligand Equivalent to LUTATHE... Read Post »
New Drug ApprovalFDA Approves Ameluz PDT for Superficial Basal Cell Carcinoma FDA Approves Ameluz PDT for Superficial Basal Cell Carcinoma Read Post »
Clinical TrialsContineum’s JNJ-5120/PIPE-307 Misses Phase 2 MDD Endpoint Contineum’s JNJ-5120/PIPE-307 Misses Phase 2 MDD Endpoint Read Post »
Clinical TrialsRevelyx Bio’s Recombinant Botulinum Toxin YY003 Shows 80.8% Response in P... Revelyx Bio’s Recombinant Botulinum Toxin YY003 Shows 80.8% Response in P... Read Post »
Clinical TrialsTrastuzumab Botidotin Improves Progression-Free Survival Versus T-DM1 in HE... Trastuzumab Botidotin Improves Progression-Free Survival Versus T-DM1 in HE... Read Post »
Clinical TrialsCorbus’s CRB-913 Shows 5% Weight Loss in Phase 1b Obesity Trial Corbus’s CRB-913 Shows 5% Weight Loss in Phase 1b Obesity Trial Read Post »
Clinical TrialsEnhertu Extends Progression-Free Survival by Six Months in First-Line HER2-... Enhertu Extends Progression-Free Survival by Six Months in First-Line HER2-... Read Post »
Clinical TrialsZipalertinib Plus Chemotherapy Improves Progression-Free Survival in First-... Zipalertinib Plus Chemotherapy Improves Progression-Free Survival in First-... Read Post »
New Drug ApprovalFDA Approves Pixclara as First FET-PET Imaging Drug for Glioma FDA Approves Pixclara as First FET-PET Imaging Drug for Glioma Read Post »
Clinical TrialsZidesamtinib Shows 94% Response Rate in ROS1-Positive NSCLC Zidesamtinib Shows 94% Response Rate in ROS1-Positive NSCLC Read Post »
Clinical TrialsRis-Rez Extends Survival in Relapsed Small Cell Lung Cancer in Phase III AR... Ris-Rez Extends Survival in Relapsed Small Cell Lung Cancer in Phase III AR... Read Post »
Clinical TrialsRoche’s Tam-Peli Cuts Death Risk by 54% in SCLC Trial Roche’s Tam-Peli Cuts Death Risk by 54% in SCLC Trial Read Post »
New Drug ApprovalPharming Wins FDA Approval to Expand Joenja to Children With APDS Pharming Wins FDA Approval to Expand Joenja to Children With APDS Read Post »
New Drug ApprovalFDA Approves ISEMBYLD as First Muscle-Targeted Therapy for Spinal Muscular ... FDA Approves ISEMBYLD as First Muscle-Targeted Therapy for Spinal Muscular ... Read Post »
Clinical TrialsStructure Advances Oral Obesity Pipeline With ACCG-2671 and Aleniglipron Da... Structure Advances Oral Obesity Pipeline With ACCG-2671 and Aleniglipron Da... Read Post »
Clinical TrialsRedasemtide Shows DEB Ulcer Closure, Misses Stroke Endpoint Redasemtide Shows DEB Ulcer Closure, Misses Stroke Endpoint Read Post »
Clinical TrialsFinal MATTERHORN Analysis Confirms Overall Survival Benefit With Durvalumab... Final MATTERHORN Analysis Confirms Overall Survival Benefit With Durvalumab... Read Post »
Clinical TrialsSetmelanotide Shows BMI and Metabolic Benefits in Paediatric Hypothalamic O... Setmelanotide Shows BMI and Metabolic Benefits in Paediatric Hypothalamic O... Read Post »
Clinical TrialsAtogepant Cuts Menstrual Migraine Days in Phase 3 LUNA Study Atogepant Cuts Menstrual Migraine Days in Phase 3 LUNA Study Read Post »
Clinical TrialsTNP-2092 Shows 100% Six-Month Success in Phase IIa Non-Surgical PJI Trial TNP-2092 Shows 100% Six-Month Success in Phase IIa Non-Surgical PJI Trial Read Post »
Clinical TrialsFDA Pauses New Enrollment in Biohaven’s Opakalim Epilepsy Program Over Ro... FDA Pauses New Enrollment in Biohaven’s Opakalim Epilepsy Program Over Ro... Read Post »
Clinical TrialsOpus Genetics Reports Visual Function Gains with OPGx-BEST1 in Phase 1/2 BE... Opus Genetics Reports Visual Function Gains with OPGx-BEST1 in Phase 1/2 BE... Read Post »
Clinical TrialsTT-P34 Phase 1 Trial Shows CNS Exposure in Parkinson’s TT-P34 Phase 1 Trial Shows CNS Exposure in Parkinson’s Read Post »
Clinical TrialsVOXZOGO (Vosoritide) Shows Significant Growth Improvements in Phase 3 Hypoc... VOXZOGO (Vosoritide) Shows Significant Growth Improvements in Phase 3 Hypoc... Read Post »
Clinical TrialsNeflamapimod Biomarker Data Set to Shed Light on Tau-Driven FTD in Phase 2a... Neflamapimod Biomarker Data Set to Shed Light on Tau-Driven FTD in Phase 2a... Read Post »
Clinical TrialsDISC-3405 Reduces Phlebotomy and Controls Hematocrit in Phase 2 Polycythemi... DISC-3405 Reduces Phlebotomy and Controls Hematocrit in Phase 2 Polycythemi... Read Post »
Clinical TrialsBeeline’s Afimetoran Meets Phase 2 Endpoint in SLE Beeline’s Afimetoran Meets Phase 2 Endpoint in SLE Read Post »
